Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000101

EVP, Chf Clinical Develop Ofcr sold 6,179 shares at $83.45 ($515,630)

  • EVP, Chf Clinical Develop Ofcr acquired 11,991 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schneider Eugene EVP, Chf Clinical Develop Ofcr 2026-01-29 Grant or award +11,991 75,881 D: show line 1 in the form
Schneider Eugene EVP, Chf Clinical Develop Ofcr 2026-01-30 Sale −6,179 $83.45 $515,630 69,702 D: show line 2 in the form
Open-market sales · 6,179 sh · avg $83.45 · $515,630
Loading xslF345X05/edgardoc.xml…